JPRN-UMIN000002919
Not yet recruiting
未知
An exploratory clinical trial of immunotherapy before surgery in stomach cancer case - An exploratory clinical trial of immunotherapy before surgery in stomach cancer case
Conditionsstage I-III stomach cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- stage I-III stomach cancer
- Sponsor
- JIKEI UNIVERSITY SCHOOL OF MEDICINE
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Fresh bleed from gastrointestinal tract 2\.Body cavity fluid accumulation 3\.Infection, intestinal tract paralysis, intestinal obstruction 4\.Pregnant patient 5\.Insulin treatment or uncontrolled diabate patient 6\.Patient with a history of ischemic cardiac disease 7\.Insanity, psychological symptom patient 8\.Stable dose of steroid patient 9\.Patient with a history of severe drug allergies 10\.Advancing infection patient 11\.Organ failure patient And patient be disqualified as target by doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical trial of immunomodulatory therapy using anti-thymocyte globulin and pegfilgrastim for recently onset type 1 diabetesType 1 diabetesJPRN-UMIN000027070Toyama University12
Recruiting
Phase 2
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase IIAsthmaBronchial DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesEnvironmental IllnessRPCEC00000240ational Center of Bioproducts (BIOCEN)120
Completed
Phase 3
A prospective randomized controlled trial of immunoglobulin plus prednisolone for Kawasaki disease patients with high risk for coronary abnormalitiesKawasaki diseaseJPRN-UMIN000009524agoya University Graduate School of Medicine, Department of Pediatrics240
Completed
Not Applicable
Trial to study the effect of Curvic® in vaccinated population for COVID-19Vaccinated for COVID-19Infections and InfestationsCOVID-19 (SARS-CoV-2 infection)ISRCTN26285740Shreepad Shree Vallabh SSV Phytopharmaceuticals50
Recruiting
Not Applicable
A Pilot Study of Adoptive Immunotherapy Comprising 2-Methyl-3-Butenyl-1-Pyrophosphate-Stimulated Gamma Delta T Cells in Patients With advanced Renal Cell Carcinomaadvanced Renal cell carcinomaJPRN-UMIN000016793Tokyo Women's Medical University10